Navigation Links
VirtualScopics, Inc. Reports a Record Breaking Quarter
Date:8/12/2009

(unaudited) For the Three Months For the Six Months Ended June 30, Ended June 30, 2009 2008 2009 2008 Revenues $2,541,316 $1,733,299 $4,675,685 $3,367,402 Cost of services 1,147,980 1,021,536 2,162,564 2,051,520 --------- --------- --------- --------- Gross profit 1,393,336 711,763 2,513,121 1,315,882 --------- ------- --------- --------- Gross margin 55% 41% 54% 39% Operating expenses Research and development 258,180 212,825 493,735 464,654 Sales and marketing 357,222 384,237 639,676 673,111 General and administrative 590,496 580,435 1,149,843 1,074,876 Stock-based compensation expense 269,016 284,228 554,348 687,291 Depreciation and amortization 119,126 116,765 236,636 234,332 ------- ------- ------- ------- Total operating expenses 1,594,040 1,578,490 3,074,238 3,134,264 --------- --------- --------- --------- Operating loss (200,704) (866,727) (561,117) (1,818,382) Other income (expense) Interest income 87 17,002 3,280 45,727 Other expense (6,592) (1,385) (8,076) (2,968) Loss on derivative financial instrument (205,914) - (603,323) - -------- --- -------- --- Total other (expense) income
'/>"/>
SOURCE VirtualScopics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009
2. BELLUS Health reports results for first half of fiscal 2009
3. China Pharma Holdings, Inc. Reports Second Quarter 2009 Financial Results and Corporate Updates
4. VIVUS Reports Second Quarter 2009 Financial Results
5. Mesa Labs Reports Higher First Quarter Earnings
6. Physician Owned and Operated Hospitals Get Top Rankings From Consumer Reports, but They Remain on the Healthcare Reform Chopping Block
7. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
8. Winner Medical Reports Third Quarter Fiscal 2009 Results
9. Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results
10. DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results
11. Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014 A common approach to treating ... did not improve survival chances for people who suddenly ... at the University of Pittsburgh School of Medicine. , ... One , suggest acute hemodialysis, an aggressive method that ... may not provide a definitive benefit to the patient. ...
(Date:8/20/2014)... a novel approach to treating cancer - using Botox. ... Science Translational Medicine shows that cancer growth ... nerves that are linked to cancer stem cells. The ... made the treatment cheap, safe and efficient. The researchers ... will soon start testing on humans. , The nervous ...
(Date:8/20/2014)... A common approach to treating kidney failure ... improve survival chances for people who suddenly developed the ... University of Pittsburgh School of Medicine. ... PLOS One , suggest acute hemodialysis, an aggressive ... kidney failure, may not provide a definitive benefit to ...
(Date:8/20/2014)... 2014 (HealthDay News) -- New research reveals that, long ... the global spread of the infectious disease known as ... in Africa to seals and sea lions, who then ... years ago, according to an international team of researchers. ... rise again worldwide. This study and further research will ...
(Date:8/20/2014)... August 20, 2014 Get the report ... with mergermarket presents ‚ÄúDeal Drivers 2014 Half Year Report ... of M&A activity in both North and South America, ... , About Merrill DataSite     , Merrill DataSite is a ... optimises the due diligence process by providing a highly ...
Breaking Medicine News(10 mins):Health News:Pitt analysis questions use of acute hemodialysis treatment 2Health News:Treating gastric cancer -- with Botox 2Health News:Pitt Analysis Questions Use of Acute Hemodialysis Treatment 2Health News:Seals, Sea Lions Helped Global Spread of TB, Study Finds 2Health News:Register to Download Merrill DataSite's Report: Deal Drivers 2014 Half Year Report for the Americas 2
... , In an observational cohort study from ... on prevention of mother-to-child HIV transmission among women ... recommendations. , Citation: Tonwe-Gold B, Ekouevi DK, Viho ... Antiretroviral treatment and prevention of peripartum and postnatal ...
... a key gene might not be to blame, researchers say ... is poking holes in a prevailing theory on the origins ... to rein in cell-damaging free radicals actually had fewer ... "This finding may go beyond Alzheimer,s into all aging theory," ...
... in no real danger, survey finds , MONDAY, Aug. 20 ... white peers to take risks that boost their odds for ... August issue of the journal Archives of Dermatology , ... Medicine surveyed 369 high school students (221 white Hispanics and ...
... Compared with Caucasians, African-Americans are exposed to more ... of Medicine study published in this months Public Health ... preventable death and disease in the United States, causing ... $150 billion in direct and indirect costs each year; ...
... study likely applicable to men of other ethnicities, Tulane ... drinks per week) may increase the risk of stroke ... published in the latest issue of Annals of Neurology. ... of Tulane University School of Public Health and Tropical ...
... 2007 - Lissamine green sounds like the latest cleaning ... you would want to get in your eyes. , ... patterns that are key to diagnosing dry eye syndrome ... treating the potentially sight-stealing disease, new research at UT ...
Cached Medicine News:Health News:HIV therapy in pregnancy-data support WHO recommendations 2Health News:Study Puts 1 Alzheimer's Theory in Doubt 2Health News:Study Puts 1 Alzheimer's Theory in Doubt 3Health News:Hispanic Teens Take More Skin Cancer Risks 2Health News:Pitt study finds inequality in tobacco advertising 2Health News:Eye-staining technique offers early detection for dry eye syndrome 2Health News:Eye-staining technique offers early detection for dry eye syndrome 3
(Date:8/19/2014)... Aug. 19, 2014 /PRNewswire-iReach/ -- ChemImage founder and CTO, ... scientific poster describing an innovative diagnostic procedure for the ... New Light on Disease (SPEC) conference in Krakow, ... poster entitled, "Development of in vitro Diagnostics for Detection ... discussed during the conference poster session on Tuesday, August ...
(Date:8/19/2014)... Aug. 19, 2014  As power morcellator lawsuits ... Bernstein Liebhard LLP notes that women in need ... a number of options that do not involve ... According to a report published by The Wall ... options include a mini-laparotomy and vaginal hysterectomy. Non-surgical ...
(Date:8/19/2014)... -- Research and Markets has announced the addition ... Business Report" report to their offering. ... Drugs in US$ Million by the following Brands: Humatrope, Norditropin, ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , and Rest of World. ...
Breaking Medicine Technology:ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 3Global Human Growth Hormone Drugs - Strategic Business Report 2014 2
... Dec. 16 Vivakor, Inc. (OTC Bulletin Board: VIVK) ... out of Walnut Creek, California and its affiliate group, ... Consulting has been retained by Vivakor to assist with ... recently reported acquisition strategy. Specifically, Baker Consulting is exploring ...
... , EVANSTON, Ill., Dec. ... innovative treatments for depression and other CNS disorders based on ... presented at a major medical meeting showed that its lead ... signs of the CNS-related side effects seen with other drugs ...
Cached Medicine Technology:Vivakor Signs Business Development Agreement With Baker Consulting 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 3Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 5Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 6
Sabre 180 is a powerful niche generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
Finesse II electrosurgical generator (100-120 VAC) utilizes a patented design that integrates the electrosurgical generator and smoke evacuation system into a single compact unit....
Medicine Products: